Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00074165
Status:
TERMINATED
Last Update Posted:
2023-07-06
First Post:
2003-12-10
Brief Title:
Treating Patients With Recurrent PCNSL With CarboplatinBBBD and Adding Rituxan To The Treatment Regimen
Sponsor:
OHSU Knight Cancer Institute
Organization:
OHSU Knight Cancer Institute
Organization Data
Organization:
OHSU Knight Cancer Institute
Class:
OTHER
Study ID:
IRB00000641
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
OHSU Knight Cancer Institute
Lead Sponsor Class:
OTHER
Responsible Party:
Edward Neuwelt
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
OHSU Knight Cancer Institute
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |